Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.61    0.205 (12.81%)
Bid:
1.61
Ask:
2.00
Spread: 0.39 (24.224%)
Market Cap: £5.65m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Block listing Interim Review

8 Oct 2018 10:31

RNS Number : 2793D
Proteome Sciences PLC
08 October 2018
 

 

 

Proteome Sciences plc

 

Block Admission return

 

 

 

Name of company:

Proteome Sciences plc

Name of scheme:

2004 Share Option Plan

2011 Share Option Plan

Period of return:

1 April 2018 to 30 September 2018

Number of ordinary shares of 1 pence each in the company ("Ordinary Shares") not issued under the scheme at the end of the last period:

498,596

Number of Ordinary Shares issued under the scheme during the period:

-

Number of Ordinary Shares cancelled under the scheme during the period:

-

Balance of Ordinary Shares under scheme not yet issued at end of period:

498,596

Number and class of Ordinary Shares originally admitted under scheme and the date of admission

1,000,000 Ordinary Shares - 26th October, 2004

 

Enquiries:

Stefan Fuhrmann 020 7043 2116

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRKVLBBVBFXFBB
Date   Source Headline
4th Dec 20084:36 pmRNSPrice Monitoring Extension
7th Nov 200811:05 amRNSChange of NOMAD
31st Oct 200812:10 pmRNSTotal Voting Rights
28th Oct 200812:36 pmRNSBlocklisting Interim Review
22nd Oct 20084:42 pmRNSSecond Price Monitoring Extn
22nd Oct 20084:37 pmRNSPrice Monitoring Extension
20th Oct 20089:38 amRNSHolding(s) in Company
13th Oct 200810:54 amRNSHolding(s) in Company
8th Oct 20082:58 pmPRNChange of Adviser Name
1st Oct 20084:41 pmRNSSecond Price Monitoring Extn
1st Oct 20084:37 pmRNSPrice Monitoring Extension
30th Sep 20087:00 amRNSInterim Results
30th Sep 20087:00 amPRNInterim Results
16th Sep 20084:48 pmRNSSecond Price Monitoring Extn
16th Sep 20084:43 pmRNSPrice Monitoring Extension
5th Aug 20083:37 pmPRNHolding(s) in Company
1st Aug 20084:40 pmRNSSecond Price Monitoring Extn
1st Aug 20084:35 pmRNSPrice Monitoring Extension
31st Jul 20084:13 pmPRNDirector Dealing
30th Jul 20084:40 pmRNSSecond Price Monitoring Extn
30th Jul 20084:35 pmRNSPrice Monitoring Extension
28th Jul 20081:58 pmPRNResult of AGM and Update
2nd Jul 20083:42 pmPRNNotifiable Interest
27th Jun 20089:50 amPRNAnnual Report and Accounts
24th Jun 20087:05 amPRNLoan Agreement
24th Jun 20087:00 amPRNFinal Results
12th Jun 20087:00 amPRNNotice of Allowance for US Patent
20th May 20082:43 pmPRNHolding(s) in Company
8th May 20087:00 amPRNSENS-IT-IV Framework 6 EU Grant Award
25th Apr 20082:30 pmPRNBlocklisting - Interim Review
17th Apr 200810:28 amPRNTotal Voting Rights
1st Apr 20083:20 pmPRNHolding(s) in Company
20th Mar 200812:22 pmPRNTMT Patent Update
13th Mar 20082:55 pmPRNHolding(s) in Company
13th Mar 20082:52 pmPRNHolding(s) in Company
20th Feb 20082:26 pmPRNHolding(s) in Company
18th Feb 200812:25 pmPRNHolding(s) in Company
14th Feb 20085:45 pmPRNHolding(s) in Company
13th Feb 20083:04 pmPRNHolding(s) in Company
5th Feb 20088:36 amPRNStatement re Share Price Movement
23rd Jan 20084:21 pmPRNHolding(s) in Company
18th Jan 20083:53 pmPRNHolding(s) in Company
21st Dec 20077:00 amPRNCurrent Trading
20th Nov 20075:24 pmPRNNotifiable Interests
20th Nov 20075:01 pmPRNNotifiable Interest
19th Nov 20074:33 pmPRNNotifiable Interest (TR-1)
13th Nov 20075:38 pmPRNStatement re Issuance of US Patent
5th Nov 20073:57 pmPRNNotifiable Interest
31st Oct 20077:00 amPRNBlocklisting - Interim Review
10th Oct 20073:31 pmPRNNotifiable Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.